Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058287) titled 'A Prospective Study on Tumor Immunogenomics in Renal and Urothelial Malignancies' on June 26.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Renal and Urothelial cancers
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To investigate the underlying mechanisms contributing to the progression of genitourinary cancers and the development of resistance to therapeutic agents.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 10
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients diagnosed wi...